| Literature DB >> 19251751 |
Jason W Busse1, Jagdeep Kaur, Brent Mollon, Mohit Bhandari, Paul Tornetta, Holger J Schünemann, Gordon H Guyatt.
Abstract
OBJECTIVE: To determine the efficacy of low intensity pulsed ultrasonography for healing of fractures.Entities:
Mesh:
Year: 2009 PMID: 19251751 PMCID: PMC2651102 DOI: 10.1136/bmj.b351
Source DB: PubMed Journal: BMJ ISSN: 0959-8138
Characteristics of included trials
| Trial | Fracture location | No of patients randomised (No analysed) | Mean (SD) age | Duration of low intensity pulsed ultrasonography | Outcome measures recorded | ||
|---|---|---|---|---|---|---|---|
| Treatment group | Control group | ||||||
| Fresh fracture: | |||||||
| Kristiansen et al 1997w2 | Distal radius | 40 (30) | 45 (31) | Treatment: 54 (3*); control: 58 (2*) | 70 days | Time to early trabecular bridging†; time to cortical bridging (first, second, third, and fourth)†; time to organised trabecular bridging† | |
| Mayr et al 2000w3 | Scaphoid | 15 (15) | 15 (15) | 37 (14) | Until cast was removed | Time to cast removal†; % of patients with bridging of fracture at 4, 6, 8, 10, and 12 weeks†‡; time to ≥70% bridging of fracture† | |
| Heckman et al 1994w1 | Tibia | 48 (33); 31 closed, 2 grade I open | 49 (34); 33 closed, 1 grade I open | Treatment: 36 (2.3*); control: 31 (1.8*) | 140 days, or until study investigator deemed fracture was healed | Time to bridging of three cortices†; time to bridging of four cortices†; time to endosteal healing†; time to clinical healing (fracture stable and not painful to manual stress)†; time to cast removal†; days to start of weight bearing | |
| Lubbert et al 2008w15 | Clavicle | 61 (52) | 59 (49) | Treatment: 38 (13); control: 37 (12) | 28 days | Fracture consolidation according to patient; need for operative fixation; analgesic use; pain; adverse events; non-union; resumption of sport, professional, or household activities | |
| Stress fracture: | |||||||
| Rue et al 2004w4 | Tibia | 14 (14) | 12 (12) | Treatment: 18.6 (0.8); control: 18.4 (0.8) | Until fracture was asymptomatic and healed on x ray film | Return to full participation and duty | |
| Distraction osteogenesis: | |||||||
| Schortinghuis et al 2005w5 | Mandible | 4 (4) | 4 (4) | 65 (8.8) | From first day of distraction until implant inserted (mean 13.0 (SD 1.5) hours) | Microradiography gap fill area; gap grey percentage; histology gap fill length; histological score; patient ease of use questionnaire | |
| El-Mowafi and Mohsen 2005w6 | Tibia | 10 (10) | 10 (9) | 35 (range 18-45) | Until removal of external fixator | Healing index (duration of external fixation divided by length of distraction gap)† | |
| Tsumaki et al 2004w14 | Tibia | 21 (21) | 21 (21) | 68 (range 53-78) | Until removal of external fixator | Bone mineral density in distraction callus†; bone mineral density distal to distraction gap; consolidation period; duration of fixator use | |
| Bone graft for non-union: | |||||||
| Ricardo 2006w10 | Scaphoid | 10 (10) | 11 (11) | 26.7 (range 17-42) | Until fracture healed clinically and radiographically | Overall time to clinical (no pain or tenderness) and radiographic healing† | |
| Fresh fracture: | |||||||
| Handolin et al 2005w7 | Lateral malleolus | 11 (10) | 11 (11) | Treatment: 37.5 (range 18-54); control: 45.5 (range 26-59) | 42 days | Prevalence of fracture line visualisation at 2, 6, 9, and 12 weeks; prevalence of external callus formation at 2, 6, 9, and 12 weeks; % of bone healing at 2 and 9 weeks | |
| Handolin et al 2005w8 w9 | Lateral malleolus | 15 (15)§ | 15 (15)§ | Treatment: 41.4 (range 19-65); control: 39.4 (range 18-59) | 42 days | Prevalence of callus formation at 2 ,6, 9, and 12 weeks; radiographic healing at 72 weeks; Olerud-Molander score at 72 weeks; clinical examination of ankle at 72 weeks; bone mineral density at 12 and 72 weeks | |
| Emami et al 1999w11 w12 | Tibia | 15 (15)¶; 12 closed, 3 open | 17 (17)¶; 16 closed, 1 open | Treatment: 39.9; control: 34.3 | 75 days | Time to appearance of first callus; time to bridging of three cortices; time to full weight bearing; level of cross linked telopeptide over one year †**; level of bone specific alkaline phosphatase over one year; level of osteocalcin | |
| Leung et al 2004w13 | Tibia | 16 (16); 7 closed, 9 open | 14 (14); 6 closed, 8 open | 35.3 (range 22-61) | 90 days | Disappearance of tenderness at fracture site††; time to partial weight bearing; time to full weight bearing†; duration of external fixator use†; time to appearance of first, second, and third callus†; % change in bone mineral content at fracture site at 11 time points over 30 weeks†‡‡; % change in bone specific alkaline phosphatase at 13 time points over 30 weeks†§§ | |
*Standard error
†Difference between groups was statistically significantly (P<0.05) in favour of low intensity pulsed ultrasonography.
‡Significant differences were reported at weeks 4, 6, and 8.
§Only eight in each group were available for 17 week follow-up.
¶One patient was excluded from the study, but authors did not clarify from which group. For laboratory blood assays, only 30 patients were analysed (15 per group).
**Differences were only significant (lower level of cross linked telopeptide in low intensity pulsed ultrasonography group) at week 1.
††Leung et alw13 reported a significant difference in favour of low intensity pulsed ultrasonography, but reanalysis of their data with two sided t test showed non-significant difference between treatment and control groups (P=0.09).
‡‡Significant differences reported at weeks 6, 15, 18, and 21.
§§Significant differences reported at weeks 12, 18, and 27.

Fig 1 Flow of trials through study. *Two sets of trials reported on common patient samples and were considered as single studies
Methodological quality of eligible randomised controlled trials
| Trial | Concealment of treatment allocation | Patients blinded | Caregivers blinded | Outcome assessors blinded | Loss to follow-up (%) |
|---|---|---|---|---|---|
| Fresh fracture: | |||||
| Kristiansen et al 1997w2 | Yes | Yes | Yes | Yes | 28 |
| Mayr et al 2000w3 | Unclear | No | No | Yes | 0 |
| Heckman et al 1994w1 | Yes | Yes | Yes | Yes | 31 |
| Lubbert et al 2008w15 | Yes | Yes | Yes | Yes | 16 |
| Stress fracture: | |||||
| Rue et al 2004w4 | Yes | Yes | Yes | Yes | 0 |
| Distraction osteogenesis: | |||||
| Schortinghuis et al 2005w5 | Yes | Yes | Yes | Yes | 0 |
| El-Mowafi and Mohsen 2005w6 | Unclear | Unclear | Unclear | Unclear | 5 |
| Tsumaki et al 2004w14 | Yes | No | No | No | 0 |
| Bone graft for non-union: | |||||
| Ricardo 2006w10 | Yes | Yes | Yes | Yes | 0 |
| Fresh fracture: | |||||
| Handolin et al 2005w7 | Yes | Yes | Yes | Yes | 5 |
| Handolin et al 2005w8 w9 | Yes | Yes | Yes | Yes | 0% for 12 week follow-up; 47% for 18 month follow-up |
| Emami et al 1999w11 w12 | Yes | Yes | Yes | Yes | 3 |
| Leung et al 2004w13 | Unclear | Unclear | Unclear | Unclear | 0 |

Fig 2 Effect of low intensity pulsed ultrasonography on radiographic healing of fractures
GRADE evidence profile: randomised controlled trials of low intensity pulsed ultrasonography for more rapid return to function (often measured by surrogate of radiographic fracture healing)
| No of studies (No of patients) | Limitations | Consistency | Directness | Precision | Publication bias | Magnitude of effect (95% CI) | Overall quality |
|---|---|---|---|---|---|---|---|
| Return to function: | |||||||
| 1 trial (n=101) | No limitations | No important inconsistency | Direct | Imprecise* | Unlikely | Faster return to function† 1.40 days (−0.56 to 3.36) | Moderate |
| Radiographic healing: | |||||||
| 3 trials (n=158) | Limitations‡ | No important inconsistency | Indirect§ | Precision adequate | Potential¶ | Reduction in healing time 36.9% (25.6% to 46.0%) | Low |
| Return to function: | |||||||
| 1 trial (n=26) | No limitations | No important inconsistency | Direct | Imprecise* | Unlikely | Faster return to active duty 0.4 days (−13.1 to 13.9) | Moderate |
| Radiographic healing: | |||||||
| 1 trial (n=21) | No limitations | No important inconsistency | Indirect§ | Imprecise** | Potential¶ | Reduction in healing time 40.4% (30.8% to 48.7%) | Low |
| Return to function: | |||||||
| 2 trials†† (n=61) | Serious limitations‡‡ | Important inconsistency | Direct | Imprecise* | Unlikely | Faster return to full weight bearing 3.4 weeks (−2.1 to 8.9) | Low |
| Radiographic healing: | |||||||
| 2 trials (n=61) | Serious limitations‡‡ | Important inconsistency | Indirect§ | Imprecise* | Unlikely | Reduction in healing time 16.6% (−76.8% to 60.7%) | Very low |
*95% confidence interval included both important benefit and harm.
†As patient assessed fracture healing, resumption of household activities, return to work, and resumption of sport measure same underlying domain (functional recovery), data from these four end points were pooled to improve precision of outcome measure.
‡Loss to follow-up was about 30% in two trials, and third trial did not blind participants or providers and it is not certain that allocation was concealed.
§Evidence is provided by surrogate measure only (radiographic healing).
¶As a result of small number of trials and inconsistent reporting of outcomes across trials. Overall quality rating was not decreased on basis of suspicion of publication bias.
**Although confidence interval appears adequately narrow, the sample size failed to meet the optimal information size.
††A third, negative, trial by Handolin et alw9 reported on a functional outcome, mean Olerud-Molander score, but did not provide the associated measure of variance to allow for statistical pooling.
‡‡Uncertain if, in positive trial by Leung et alw13, allocation was concealed or if patients, care givers, or outcome assessors were blinded. Quality was not, however, downgraded.